Carysil (524091) Aperçu de l'action
Carysil Limited, avec ses filiales, fabrique et commercialise des éviers de cuisine en quartz et en acier inoxydable, des produits pour le bain, des carrelages, des appareils de cuisine et des accessoires en Inde. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 1/6 |
| Croissance future | 3/6 |
| Performances passées | 5/6 |
| Santé financière | 6/6 |
| Dividendes | 3/6 |
Récompenses
Analyse des risques
Aucun risque n'a été détecté pour 524091 à partir de nos contrôles de risques.
524091 Community Fair Values
Create NarrativeSee what 14 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Carysil Limited Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | ₹1,177.80 |
| Plus haut sur 52 semaines | ₹1,249.95 |
| Plus bas sur 52 semaines | ₹734.00 |
| Bêta | 0.56 |
| Variation sur 1 mois | 7.54% |
| Variation sur 3 mois | 48.99% |
| Variation sur 1 an | 35.44% |
| Variation sur 3 ans | 67.18% |
| Variation sur 5 ans | 88.03% |
| Évolution depuis l'introduction en bourse | 127,000.81% |
Nouvelles et mises à jour récentes
524091: Subsidiary Simplification And Dividend Plans Will Shape Future Share Performance
Analysts have kept their fair value estimate for Carysil steady at ₹1,270.50, with the small adjustments in discount rate, revenue growth, profit margin and future P/E assumptions leading to only a marginal refinement in the overall price target narrative. What’s in the News for Carysil Board meeting on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on equity shares for the financial year ended March 31, 2026.524091: Subsidiary Simplification And Dividend Policy Will Support Future Upside
Carysil’s analyst price target is unchanged at ₹1,270.5, as analysts balance slightly adjusted assumptions for discount rate, revenue growth, profit margins and future P/E to arrive at the same fair value estimate. What's in the News A board meeting is scheduled for May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on the equity shares for FY 2025-26.524091: Subsidiary Rationalisation And QIP Extension Will Support Future Upside
Carysil’s analyst price target has changed from ₹1,205.67 to ₹1,270.50 as analysts incorporate slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a modestly higher fair value estimate. What's in the News A board meeting is scheduled on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider and recommend a final dividend, if any, on equity shares for the financial year ended March 31, 2026 (Key Developments).Recent updates
524091: Subsidiary Simplification And Dividend Plans Will Shape Future Share Performance
Analysts have kept their fair value estimate for Carysil steady at ₹1,270.50, with the small adjustments in discount rate, revenue growth, profit margin and future P/E assumptions leading to only a marginal refinement in the overall price target narrative. What’s in the News for Carysil Board meeting on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on equity shares for the financial year ended March 31, 2026.524091: Subsidiary Simplification And Dividend Policy Will Support Future Upside
Carysil’s analyst price target is unchanged at ₹1,270.5, as analysts balance slightly adjusted assumptions for discount rate, revenue growth, profit margins and future P/E to arrive at the same fair value estimate. What's in the News A board meeting is scheduled for May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on the equity shares for FY 2025-26.524091: Subsidiary Rationalisation And QIP Extension Will Support Future Upside
Carysil’s analyst price target has changed from ₹1,205.67 to ₹1,270.50 as analysts incorporate slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a modestly higher fair value estimate. What's in the News A board meeting is scheduled on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider and recommend a final dividend, if any, on equity shares for the financial year ended March 31, 2026 (Key Developments).524091: Subsidiary Rationalisation And QIP Timeline Extension Will Support Future Upside
Analysts have kept Carysil’s fair value estimate broadly unchanged at about ₹1,205.67, with only small tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, leading to a steady overall price target narrative. What's in the News Board meeting scheduled on Mar 20, 2026 at 15:00 IST to review the appointment of an internal auditor and a cost auditor.524091: Subsidiary Closures And QIP Utilisation Decisions Will Support Future Upside
Analysts have kept their average price target for Carysil broadly steady at around ₹1,205.67, citing largely unchanged assumptions on revenue growth, profit margins and future P/E, with only minor adjustments to the discount rate in their models. What's in the News A board meeting is scheduled on Feb 04, 2026 to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).524091: Upcoming Board Decisions On Subsidiary Closures Will Support Future Upside
Analysts have kept their fair value estimate for Carysil steady at ₹1,205.67 per share, with only minimal tweaks to inputs such as the discount rate, revenue growth outlook, profit margin assumptions and future P/E. This reflects a view that recent data does not materially change the stock’s underlying valuation story.524091: Upcoming Board Results And Stable Assumptions Will Support Future Upside
Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, while making refinements to inputs such as a slightly lower discount rate and minor adjustments to revenue growth, profit margin, and future P/E expectations to reflect updated assumptions in their models. What's in the News Carysil has scheduled a board meeting for February 4, 2026 to review and approve unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).524091: Upcoming Results And Steady Assumptions Will Support Future Upside
Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, making only minor model adjustments, such as a slightly higher discount rate and a modestly higher assumed future P/E multiple. These changes together leave the overall price target unchanged.524091: Upcoming Results And Improved Margin Outlook Will Support Future Upside
Analysts have nudged their fair value estimate on Carysil higher from ₹1,165 to about ₹1,206, citing updated assumptions on discount rate, revenue growth, profit margins and future P/E that better reflect their current expectations for the business. What's in the News Carysil has scheduled a board meeting on February 4, 2026, to consider and approve its unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).524091: Steady Outlook And Upcoming Results Date Will Support Future Upside
Analysts have kept their fair value estimate for Carysil steady at ₹1,165, with only marginal tweaks to inputs like the discount rate and assumed future P/E. This reflects fine tuning of their models rather than a change in their core view.524091: Steady Assumptions And Upcoming Results Will Support Future Upside
Analysts have maintained their price target for Carysil at ₹1,165 per share. This unchanged view mainly reflects consistent assumptions regarding fair value, discount rate, revenue growth, profit margin and future P/E.524091: Capacity Expansion Will Drive Future Earnings Momentum
Analysts have modestly raised their price target on Carysil to ₹1,165 per share (from ₹1,165), reflecting slightly higher discount rate and valuation assumptions while keeping long term growth and margin expectations broadly unchanged. What's in the News Carysil has scheduled a board meeting on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).524091: Capacity Expansion And Dividend Increase Will Drive Upward Momentum
Analysts have raised their price target for Carysil from ₹1,130.33 to ₹1,165.00, citing improved forecasts for revenue growth and profit margins that support a higher fair value estimate. What's in the News A board meeting is scheduled for November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).524091: New Capacity Expansion And Dividend Increase Set To Shape Outlook
Analysts have increased Carysil's fair value estimate from ₹1,039 to ₹1,130.33, citing modest changes in growth forecasts and profit margins, which support a slightly higher valuation target. What's in the News Carysil's board will meet on November 10, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).Global Kitchen Upgrades And Market Expansion Will Transform Industry
Carysil’s consensus price target has been raised to ₹1039, reflecting a notable improvement in future earnings valuation as indicated by the decline in its forward P/E and a marginal uplift in expected revenue growth. What's in the News Board meeting scheduled to consider investment in a subsidiary company.
Partnerships With IKEA And Karran USA Will Drive Global Expansion In Kitchen Solutions
Carysil's global expansion and strategic partnerships in the U.S. are expected to significantly drive revenue growth and increase market presence.Rendement pour les actionnaires
| 524091 | IN Building | IN Marché | |
|---|---|---|---|
| 7D | -2.1% | -1.9% | -0.5% |
| 1Y | 35.4% | -6.5% | -2.3% |
Rendement vs Industrie: 524091 a dépassé le secteur Indian Building qui a rapporté -6.5 % au cours de l'année écoulée.
Rendement vs marché: 524091 a dépassé le marché Indian qui a rapporté -2.3 % au cours de l'année écoulée.
Volatilité des prix
| 524091 volatility | |
|---|---|
| 524091 Average Weekly Movement | 7.0% |
| Building Industry Average Movement | 7.5% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.4% |
Cours de l'action stable: 524091 n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché Indian.
Volatilité au fil du temps: La volatilité hebdomadaire de 524091 ( 7% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1987 | n/a | Chirag Parekh | www.carysil.com |
Carysil Limited, avec ses filiales, fabrique et commercialise des éviers de cuisine en quartz et en acier inoxydable, des produits pour le bain, des carrelages, des appareils de cuisine et des accessoires en Inde. Elle propose des robinets et des broyeurs de déchets alimentaires, des surfaces de cuisine, des carreaux design en quartz, des appareils de cuisine encastrés, notamment des cheminées, des tables de cuisson, des refroidisseurs de vin, des lave-vaisselle, des fours encastrés, des fours à micro-ondes, des plaques de cuisson, des cuisinières, des machines à glace et à café, et d'autres produits, ainsi que des produits de salle de bains, notamment des toilettes, des raccords et des robinets. L'entreprise vend ses produits sous les marques Tekcarysil, Carysil et Sternhagen.
Carysil Limited Résumé des fondamentaux
| 524091 statistiques fondamentales | |
|---|---|
| Capitalisation boursière | ₹33.50b |
| Bénéfices(TTM) | ₹981.90m |
| Recettes(TTM) | ₹9.24b |
Le site 524091 est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| 524091 compte de résultat (TTM) | |
|---|---|
| Recettes | ₹9.24b |
| Coût des recettes | ₹4.28b |
| Marge brute | ₹4.96b |
| Autres dépenses | ₹3.97b |
| Les revenus | ₹981.90m |
Derniers bénéfices déclarés
Mar 31, 2026
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | 34.52 |
| Marge brute | 53.63% |
| Marge bénéficiaire nette | 10.63% |
| Ratio dettes/capitaux propres | 43.9% |
Quelles ont été les performances à long terme de 524091?
Voir les performances historiques et les comparaisonsDividendes
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/06/26 18:09 |
| Cours de l'action en fin de journée | 2026/06/25 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2026/03/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d'analyse utilisé pour générer ce rapport sont disponibles sur notre page Github, nous proposons également des guides pour apprendre à utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Carysil Limited est couverte par 7 analystes. 3 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Rishab Bothra | Anand Rathi Shares and Stock Brokers Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Vyom Chheda | BP Wealth Management Private Limited |